News
Guardant Health (GH) recently announced a key partnership with PathGroup and a clinical readout update, driving a 21% increase in their share price over the last quarter. The expanded reach of the ...
Wave Life Sciences (WVE) recently announced positive results from its Phase 1b/2a RestorAATion-2 study of WVE-006, showing favorable safety and promising clinical implications in treating alpha-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback